|
In This Issue
|
|
6th Annual Frontiers in Therapeutics
and Diagnostics (FTD) Forum
|
|
Happy Holidays!
|
|
Online Registration
|
|
|
|
|
Subscribe to our WeChat
|
|
|
| |
|
Greetings from SABPA!
Credit: Hao Jiang
During this holiday season, we would like to express our gratitude to SABPA volunteers, members, speakers, sponsors, and event attendees. The world is still under the shadow of the COVID in 2021 and SABPA is no exception. Facing the challenges, SABPA volunteers have showed great resilience and flexibility by adopting alternative ways to achieve our missions.
The FTD committee organized the first whole day SABPA online event in March. They mobilized volunteers from different background, surveyed a large audience, covered 6 hot topics by setting up concurrent sessions, overcame numerous technical difficulties and held a successful event with more than 700 registrations!
FTD was only a beginning. The first online BioPharma conference, the first virtual job fair by a joint SD-OCLA ECD team, virtual online BioPartnering events, E-Club team seminars, were all the efforts from SABPA to serve the local biomedical community during this special time. We are proud of our volunteers and thankful for the support from the speakers, sponsors, and attendees.
The current spread of the Omicron variant highlights the uncertainties we will face in the coming year. The SABPA team is determined to be more adaptive than the virus. While we hope for the best, we are also evaluating more interactive online platform such as Gather.Town in case we still need to stay online.
2022 marks the 20th year of SABPA’s excellent service to the Southern California biomedical and Pharmacuetical community. SABPA’s growth needs your continued support. If you share the our vision, you can either become a volunteer, join as a member, sponsor a SABPA event, or simply donate to SABPA.
Thank you and wish you all a very happy holiday season and a fruitful 2022!
Sincerely,
Tao Wu, President of SABPA-SD
Hua Gong, President Elect of SABPA-SD
The annual SABPA Frontiers in Therapeutics and Diagnostics (FTD) Forum
The annual SABPA Frontiers in Therapeutics and Diagnostics (FTD) Forum is one of the flagship events of SABPA. The 6th FTD Forum will focus on the latest progress in AI-assisted drug discovery and the recent development of nucleotide-based therapeutics. This year's keynote speakers include Professor Robert Langer from MIT and Dr. Kai-Fu Lee from Sinovation Ventures. The Forum will be in a virtual format with several concurrent sessions by key opinion leaders of the highest caliber and panel discussions covering the hottest topics in drug discovery and development, spatial genomics, synthetic lethality, wearable medical devise, and ADC and bispecific antibody therapeutics. The audience will have great opportunities to ask questions, share ideas, learn from the experts and network with their peers.
Program Highlights and Confirmed Speakers:
Kai-Fu Lee, CEO, 创新工场(Sinovation Ventures)
Robert, Langer, Professor, MIT
Andrew Adams, VP, Eli Lilly
Zhen Li, CEO, AdaRx
Mike Flanagan, CTO, Avidity
Hui Li，President and CEO，Adcentrx
Yi Liu, CEO, Kumquat
Joe Beechem, SVP, NanoString
Peter Huang, SVP, Zentalis
Suixiong Cai, SVP and CTO, Impact
Sheng Xu, Professor, UCSD
Michelle Khine, Professor, UCI
Online Registration would come to you soon!
Free Job Posting on SABPA Website
In response to the increasing recruiting demand from the local biomedical community, SABPA is waiving the fee requirement for posting job positions. If have the needs to post job positions on the SABPA website, please send the following to info.jobs@SABPA.org:
-
Job description(s) in Word format
-
“How to apply” information or contact of HR
Please be advised that the default expiration date is 3 months. Please let us know if you want us to change that. Even though we will waive the job posting fee, voluntary payment for the service is appreciated.
SABPA Community News
Happy holiday! SABPA is pleased to share with you the following achievement from the SABPA community in the past month:
Dr. Xin Jiang, Co-Founder and VP at Protego Biopharma, SABPA member since 2006
– Protego as an awardee of the J&J Quickfire Challenge for improving detection of AL Amyloidosis (IDEA)
Protego Biopharma is developing small molecule pharmacological chaperones and UPR modulators for the treatment of protein misfolding diseases. Together with City of Hope, Mayo Clinic, Memorial Sloan Kettering Cancer Center and others, Protego Biopharma recently became an awardee of the Johnson & Johnson Quickfire Challenge for improving detection of AL Amyloidosis (IDEA). The funding will expedite the development of our specific and sensitive assay for the detection of AL Amyloidosis.
https://lnkd.in/gMEaYK8r
We are excited to hear the good news and look forward to Xin’s continued success!
|
